Fresenius Medical Care North America (FMCNA), a division of Fresenius Renal Therapies has unveiled the CLiC device, the latest technological developments of their Crit-Line technology product line to support hemodialysis treatment.

The CLiC device is instrumental during a hemodialysis (HD) treatment, where it non-invasively measures hematocrit, oxygen saturation and percent change in intravascular blood volume.

It is integrated into the 2008T hemodialysis machine and offers immediate, real-time access to a patient’s hematocrit, percent change in blood volume and oxygen saturation data, as well as essential dialysis treatment information required to shape the intradialytic procedure.

Fluid overload is a common and serious problem that creates severe complications in dialysis patients and is a major cause of reported hospitalisations.

The CLiC device is designed to enable the health care professional to remove the maximum amount of fluid from the hemodialysis patient while preventing the common symptoms of dialysis such as nausea, cramping and vomiting.

“The CLiC device represents a significant step forward in the evolution of volume management.”

FMCNA chief medical officer Frank Maddux said: “The CLiC device represents a significant step forward in the evolution of volume management.

“By assisting clinical staff in managing hemodialysis patients’ complex fluid and intravascular volume conditions, the CLiC will be a valuable tool for clinicians.

“Moreover, with the integration of the CLiC device into the 2008T machine, clinical staff can more quickly recognise a patient’s risk for low-blood pressure during hemodialysis resulting from certain ultrafiltration and intravascular blood volume characteristics.

“Once the CLiC device alerts staff, they can pause ultrafiltration until the clinicians can assess the situation of their patient.”

Image: An image of a hemodialysis unit’s dialysate solution tanks. Photo: courtesy of BillpSea.